Skip to main content
profile image
Selected Works of Philip Mease, MD
Article
074. LONG-TERM (UP TO 156 WEEKS) SAFETY PROFILE OF ORAL APREMILAST IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED ANALYSIS OF PALACE 1–3
Rheumatology (2017)
  • Philip J. Mease, University of Washington
  • Dafna D. Gladman, Toronto Western Hospital
  • Juan J. Gomez-Reino, University of Santiago de Compostela
  • Stephen Hall, Monash University
  • Arthur Kavanaugh, University of California, San Diego
  • Eric Lespessailles, University of Orléans
  • Georg Schett, University of Erlangen-Nuremberg
  • Maria Paris, Celgene
  • Lichen Teng, Celgene
  • Helena Marzo-Ortega, University of Leeds
  • Jürgen Wollenhaupt, Hochschule Hannover
Link
Disciplines
Publication Date
January 4, 2017
DOI
10.1093/rheumatology/kex062.074
Citation Information
Philip J. Mease, Dafna D. Gladman, Juan J. Gomez-Reino, Stephen Hall, et al.. "074. LONG-TERM (UP TO 156 WEEKS) SAFETY PROFILE OF ORAL APREMILAST IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED ANALYSIS OF PALACE 1–3" Rheumatology Vol. 56 (2017)
Available at: http://works.bepress.com/philip-mease/61/